By Ryan Basen
During a discussion at a New York conference in October, Kevin Chen described something so esoteric, so innovative within the cannabis industry, that New Scientist later published a story about it.
What Chen described was cellular agriculture, which uses genetic modification to craft products with certain amounts of specified cannabinoids. Proponents have been applying this process elsewhere to uncured meats, while innovators within the cannabis industry espouse another potential target: to efficiently develop products rich in THC, CBD, or other cannabinoids, tailored to treat medical conditions and serve the recreational market with reliable, consistent ingredients.
Read more at Leafly